文献

J-GLOBAL ID：201702248111173277   整理番号：17A0088118

カオリンに基づく活性化血液凝固時間に及ぼす血液希釈のIn vitroおよびin vivo効果は,ヘパリン用量反応技術を使用するヘパリンの必要量を予測した

In vitro and in vivo effects of hemodilution on kaolin-based activated clotting time predicted heparin requirement using a heparin dose-response technique

著者 (7件)： Ichikawa Junko (Department of Anesthesiology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan) ,  Hagihira Satoshi (Department of Anesthesiology and Intensive Care Medicine, Osaka University, Suita, Osaka, Japan) ,  Mori Testu (Department of Anesthesiology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan) ,  Kodaka Mitsuharu (Department of Anesthesiology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan) ,  Nishiyama Keiko (Department of Anesthesiology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan) ,  Ozaki Makoto (Department of Anesthesiology, Tokyo Women’s Medical University Hospital, Tokyo, Japan) ,  Komori Makiko (Department of Anesthesiology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan)
資料名： Journal of Anesthesia  (Journal of Anesthesia)
巻： 30  号： 6  ページ： 923-928  発行年： 2016年 
JST資料番号： L0489A  ISSN： 0913-8668  CODEN： JANEEC  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： ヘパリン用量反応技術(HDR)は,一定用量ヘパリン大量瞬時投...

シソーラス用語： *時間 ,...
準シソーラス用語： *活性化凝固時間 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0088118&from=J-GLOBAL&jstjournalNo=L0489A") }}

著者キーワード (4件)： Hemodilution ,  Antithrombin ,  Heparin requirement ,  Heparin dose-response

分類 (2件)： 血液の臨床医学一般  (GK01030Y) ,  血液・体液作用薬の臨床への応用  (GW14020X)

引用文献 (30件)：

• Hattersley PG. Activated coagulation time of whole blood. JAMA. 1966;196:436-40.
• Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685-9.
• Akl BF, Vargas GM, Neal J, Robillard J, Kelly P. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1980;79:97-102.
• Raymond PD, Ray MJ, Callen SN, Marsh NA. Heparin monitoring during cardiac surgery. Part 1: Validation of whole-blood heparin concentration and activated clotting time. Perfusion. 2003;18:269-76.
• Despotis GJ, Joist JH, Hogue CW Jr, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1995;110:46-54.

タイトルに関連する用語 (7件)： カオリン ,  活性化 ,  血液凝固時間 ,  血液希釈 ,  ヘパリン ,  用量 ,  予測